Registry of Japanese Patients with Atrial Fibrillation Focused on anticoagulant therapy in New Era:The RAFFINE Study

Registry of Japanese Patients with Atrial Fibrillation Focused on anticoagulant therapy in New Era:The RAFFINE Study - Atrial fibrillation Patients Registry Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000009617

Enrollment

4000

Registered

2013-01-01

Start date

2013-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients aged 20 years or older with a diagnosis of AF will be eligible for enrollment. We will enroll a consecutive series of AF patients of all types (paroxysmal, persistent and permanent) under regular clinical observation (longer than three months) in the outpatient clinic at each institution.

Exclusion criteria

Exclusion criteria: Patients who are hospitalized, anticipated life expectancy less than one year, without consent will be excluded in this study.

Design outcomes

Primary

Measure	Time frame
The efficacy outcome: ischemic stroke or non-central nervous system systemic embolism The safety outcome: major bleeding (ISTH bleeding criteria)	—

Secondary

Measure	Time frame
all-cause mortality, cardiovascular death, myocardial infarction, heart failure-related hospitalization,newly diagnosed cancer, non-major clinically relevant bleeding	—

Countries

Japan

Contacts

Public Contacttakahama

Juntendo University Clinical reserch center

rinri@juntendo.ac.jp03-3813-3111

Outcome results